Evidence map›Paper›PMID 27834632›Full record

ArticleeLife2016

Viral factors in influenza pandemic risk assessment.

Marc Lipsitch, Wendy Barclay, Rahul Raman, Charles J Russell, Jessica A Belser, Sarah Cobey, Peter M Kasson, James O Lloyd-Smith, Sebastian Maurer-Stroh, Steven Riley and 9 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 112 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 16 institutions in 5 countries.

Marc LipsitchCenter for Communicable Disease Dynamics, Harvard T. H Chan School of Public Health, Boston, United States.ORCID 0000-0003-1504-9213
Wendy BarclayDivision of Infectious Disease, Faculty of Medicine, Imperial College, London, United Kingdom.
Rahul RamanDepartment of Biological Engineering, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, United States.
Charles J RussellDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, United States.
Jessica A BelserCenters for Disease Control and Prevention, Atlanta, United States.
Sarah CobeyDepartment of Ecology and Evolutionary Biology, University of Chicago, Chicago, United States.
Peter M KassonDepartment of Biomedical Engineering, University of Virginia, Charlottesville, United States.
James O Lloyd-SmithDepartment of Ecology and Evolutionary Biology, University of California, Los Angeles, Los Angeles, United States.ORCID 0000-0001-7941-502X
Sebastian Maurer-StrohBioinformatics Institute, Agency for Science Technology and Research, Singapore, Singapore.
Steven RileyMRC Centre for Outbreak Analysis and Modelling, School of Public Health, Imperial College London, London, United Kingdom.
Catherine Aa BeaucheminDepartment of Physics, Ryerson University, Toronto, Canada.ORCID 0000-0003-0599-0069
Trevor BedfordVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, United States.
Thomas C FriedrichDepartment of Pathobiological Sciences, University of Wisconsin School of Veterinary Medicine, Madison, United States.
Andreas HandelDepartment of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, United States.ORCID 0000-0002-4622-1146
Sander HerfstDepartment of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands.
Pablo R MurciaMRC-University of Glasgow Centre For Virus Research, Glasgow, United Kingdom.ORCID 0000-0002-4352-394X
Benjamin RocheIRD/UPMC UMMISCO, Montpellier, France.
Claus O WilkeCenter for Computational Biology and Bioinformatics, Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, United States.ORCID 0000-0002-7470-9261
Colin A RussellDepartment of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-2113-162X
Imperial College London · GBSt. Jude Children's Research Hospital · USAgency for Science, Technology and Research · SGCenter for Disease Dynamics, Economics & Policy · USCenters for Disease Control and Prevention · USFred Hutch Cancer Center · USMassachusetts Institute of Technology · USMRC University of Glasgow Centre for Virus Research · GBNational Institutes of Health · USThe University of Texas at Austin · USToronto Metropolitan University · CAUnité de Modélisation Mathématique et Informatique des Systèmes Complexes · FRUniversity of Chicago · USUniversity of Georgia · USUniversity of Virginia · USUniversity of Wisconsin–Madison · US

Funding

Understanding and controlling antibiotic resistanceU54GM088558 · NIGMS · HARVARD SCHOOL OF PUBLIC HEALTH · PI LIPSITCH, MARC · 2009 to 2018
$26.4M
Modeling the dynamics and evolution of immune responses to influenza virusesU19AI117891 · NIAID · EMORY UNIVERSITY · PI AHMED, RAFI, ANTIA, RUSTOM NOSHIR · 2015 to 2019
$8.4M
The biophysical basis of translational selectionR01GM088344 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI BARRICK, JEFFREY EVAN, WILKE, CLAUS O · 2009 to 2023
$3.5M
Models for synthesising molecular, clinical and epidemiological data, and translaU01GM110721 · NIGMS · IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE · PI CAUCHEMEZ, SIMON, FERGUSON, NEIL MORRIS · 2014 to 2018
$1.9M
Understanding fusion peptide mutations in influenza hemagglutininR01GM098304 · NIGMS · UNIVERSITY OF VIRGINIA · PI KASSON, PETER M · 2012 to 2016
$1.7M
Medical Research Council G0801822Medical Research Council MR/J008761/1Medical Research Council MR/K010174/1NIGMS NIH HHS R01 GM088344NIGMS NIH HHS R01 GM098304NIGMS NIH HHS U01 GM110721NIGMS NIH HHS U54 GM088558Wellcome TrustWellcome Trust 093488/Z/10/ZWellcome Trust 200187/Z/15/ZWellcome Trust 200861/Z/16/Z
6 · The paper itself

Abstract

The threat of an influenza A virus pandemic stems from continual virus spillovers from reservoir species, a tiny fraction of which spark sustained transmission in humans. To date, no pandemic emergence of a new influenza strain has been preceded by detection of a closely related precursor in an animal or human. Nonetheless, influenza surveillance efforts are expanding, prompting a need for tools to assess the pandemic risk posed by a detected virus. The goal would be to use genetic sequence and/or biological assays of viral traits to identify those non-human influenza viruses with the greatest risk of evolving into pandemic threats, and/or to understand drivers of such evolution, to prioritize pandemic prevention or response measures. We describe such efforts, identify progress and ongoing challenges, and discuss three specific traits of influenza viruses (hemagglutinin receptor binding specificity, hemagglutinin pH of activation, and polymerase complex efficiency) that contribute to pandemic risk.

Indexed as

PandemicsAnimalsEpidemiological MonitoringHemagglutinin Glycoproteins, Influenza VirusHumansInfluenza A virusInfluenza, HumanRisk AssessmentRNA-Dependent RNA PolymeraseVirulence FactorsZoonosesHemagglutinin Glycoproteins, Influenza VirusRNA-Dependent RNA PolymeraseVirulence Factorsepidemiologyglobal healthhumaninfectious diseaseinfluenza Amicrobiologypandemicrisk predictionvirus

Identifiers

PMID27834632
PMCPMC5156527
OpenAlexW2553154513

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.